Please login to the form below

Not currently logged in
Email:
Password:

specialty care

This page shows the latest specialty care news and features for those working in and with pharma, biotech and healthcare.

Oncology drives AstraZeneca, Genzyme boosts Sanofi

Oncology drives AstraZeneca, Genzyme boosts Sanofi

We executed on key launches in Specialty Care led by the impressive uptake of Dupixent in atopic dermatitis and asthma and also delivered strong growth in Vaccines. ... At the same time, our new GBU structure enabled us to optimise our growth opportunity

Latest news

  • AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi

    It also increases the overall Specialty Care franchise and diversifies our portfolio in Immunology.

  • Dupixent bounce-back helps stem diabetes declines at Sanofi Dupixent bounce-back helps stem diabetes declines at Sanofi

    our increasing focus on specialty care and our leadership positions in emerging markets and vaccines.”. ... Leading the charge in the specialty care category this quarter was Regeneron-partnered Dupixent (dupilumab), which has had a lumpy start since

  • Sanofi warns of difficult few months as diabetes sales slump Sanofi warns of difficult few months as diabetes sales slump

    Furthermore, with the consolidation of Bioverativ and the acquisition of Ablynx, we have established the foundation for a global rare blood disorder franchise which will further enhance our leadership in specialty ... care,” he added.

  • Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ

    In a statement the French pharma group’s chief executive - Olivier Brandicourt - said the deal “enhances its presence in specialty care and leadership in rare diseases” and will make the company ... While there is a lot of excitement about the

  • Choices, choices... Choices, choices...

    This has important practical implications. The capabilities needed to succeed with an incrementally innovative small molecule in primary-care, for example, are quite different from those needed to succeed with a ... discontinuously innovative large

More from news
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest Intelligence

  • A rare talent A rare talent

    Prior to this he held a number of roles at Astellas, most recently as specialty care director for the UK business, and country manager, for Finland, where he established the

  • Forging a path in specialty care Forging a path in specialty care

    We've already made key appointments in these areas and we're still recruiting for new talent who play an important role in the specialty care setting. ... Takeda's got off to a flying start with important speciality care products.

  • Delivering accessible healthcare Delivering accessible healthcare

    the principles of self-diagnosis, self-care and self-pay. ... As pharmaceutical companies increasingly focus on specialty care, products that can meet a mass-market medical need are becoming scarce.

  • Building a business that is lean and specialised Building a business that is lean and specialised

    He says that although Celgene is expanding, by continuing to focus on specialty products the company doesn't need hundreds of sales representatives and can continue to be lean. ... If you talk about the promotional part of market, specialty care

  • Interview: Bruno Strigini, MSD Interview: Bruno Strigini, MSD

    growth therapeutic areas are to be found not in primary care but in areas such as specialty care, orphan drugs and oncologics. ... You cannot have a drug reimbursed if you don't demonstrate superiority versus the standard of care .

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest from PMHub

  • Streaming Well

    The team take particular time and care in their work to provide contributors with the help they need to make high-quality communications materials, and it's a pleasure (I might ... care. "Streaming Well maintain upmost professionalism particularly when

  • It's time to change the conversation

    Connecting to patients, care givers and advocacy groups has become more important for some diseases. ... Although MS is considered a specialty disease and therefore treated with specialty drugs, it is in fact marketed as a primary care (RRMS), specialty

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Webinar: Usability and UX: You’ve been asked to test...What next?
Thursday 27th June 2019 10am EDT / 3pm BST / 4pm CEST...
Event: EphMRA Annual Conference
We're sponsoring, exhibiting and presenting three papers at this year’s EphMRA Annual Conference in Warsaw, Poland....
Research Partnership and Janssen awarded runner-up in MR Excellence Awards
...

Infographics